Identification of neutralizing antibodies with specificity away from the traditional mutation
prone antigenic regions, against the conserved regions of hemagglutinin from H5N1 …

The nucleoprotein (NP) possesses regions that are highly conserved among influenza A
viruses, and has therefore been one of the target viral proteins for development of a …

Background Although it has been estimated that pandemic Influenza A H1N1/2009 has
infected millions of people from April to October 2009, a more precise figure requires a …

The most effective method for the prevention of influenza infection would be prophylaxis with
a safe and effective vaccine and anti-viral materials. After vaccination, neutralizing …

Highly pathogenic avian influenza virus subtype H5N1 continues to be a severe threat to
public health, as well as the poultry industry, because of its high lethality and antigenic drift …

Abstract Avian A (H5N1) influenza virus poses an elevated zoonotic threat to humans, and
no pharmacological products are currently registered for fast-acting pre-exposure protection …

The majority of currently circulating influenza A (H1N1) viruses are antigenically similar to
the virus that caused the 2009 influenza pandemic. However, antigenic variants are …

In 2009, a novel H1N1 influenza A virus (2009 pH1N1) emerged and caused a pandemic. A
human monoclonal antibody (hMAb; EM4C04), highly specific for the 2009 pH1N1 virus …

Background Pandemic influenza poses a serious threat to global health and the world
economy. While vaccines are currently under development, passive immunization could …

Highly pathogenic avian H5 influenza viruses persist among poultry and wild birds
throughout the world. They sometimes cause interspecies transmission between avian and …